[HTML][HTML] New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, D Ma, K Wu… - Cell Communication and …, 2023 - Springer
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
[HTML][HTML] New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, D Ma, K Wu… - … and Signaling: CCS, 2023 - ncbi.nlm.nih.gov
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
New insights into the stemness of adoptively transferred T cells by γc family cytokines.
M Luo, W Gong, Y Zhang, H Li, D Ma… - Cell …, 2023 - search.ebscohost.com
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, D Ma… - Cell …, 2023 - pubmed.ncbi.nlm.nih.gov
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, D Ma, K Wu… - … and Signaling: CCS, 2023 - europepmc.org
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, M Ding… - Cell …, 2023 - search.proquest.com
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
[HTML][HTML] New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li… - Cell …, 2023 - biosignaling.biomedcentral.com
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
New insights into the stemness of adoptively transferred T cells by γc family cytokines.
M Luo, W Gong, Y Zhang, H Li, D Ma, K Wu… - … and Signaling: CCS, 2023 - europepmc.org
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
[PDF][PDF] New insights into the stemness of adoptively transferred T cells by γc family cytokines
M Luo, W Gong, Y Zhang, H Li, D Ma, K Wu, Q Gao… - 2023 - biosignaling.biomedcentral.com
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …
exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in …